Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Source Tissue

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search
Show additional data
do not include text mining results
include AMENDA results (Automatic Mining of Enzyme Data)

Search term: corpus luteum

Results 1 - 53 of 53
download as CSV
download all results as CSV
EC Number Recommended Name Source Tissue Commentary Reference
Show all pathways known for 1.1.1.141Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.14115-hydroxyprostaglandin dehydrogenase (NAD+) corpus luteum - 740130
Show all pathways known for 1.1.1.145Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.1453beta-hydroxy-DELTA5-steroid dehydrogenase corpus luteum at early and mid pregnancy up to 71 days, 3beta-hydroxysteroid dehydrogenase protein is observed in large luteal cells, while on day 71, the enzyme is present exclusively in small luteal cells. Enzyme mRNA is detected in all investigated samples isolated at different stages of pregnancy 686588
Show all pathways known for 1.1.1.145Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.1453beta-hydroxy-DELTA5-steroid dehydrogenase corpus luteum enzyme expression during diestrus, overview 670027
Show all pathways known for 1.1.1.145Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.1453beta-hydroxy-DELTA5-steroid dehydrogenase corpus luteum primary culture 670036
Show all pathways known for 1.1.1.145Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.1453beta-hydroxy-DELTA5-steroid dehydrogenase corpus luteum weak expression of 3beta-hydroxysteroid dehydrogenase in newly formed corpora lutea, which gradually increases followed by decrease on day 20. In vascularised apical region of young corpora lutea, luteal cells with more intensive immunostaining predominate. Distribution of 3beta-hydroxysteroid dehydrogenase and androgen receptor differ within various generations of corpora lutea 690002
Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.14611beta-hydroxysteroid dehydrogenase corpus luteum expression of mRNA for 11beta-hydroxysteroid dehydrogenase type 1, 11beta-hydroxysteroid dehydrogenase type 2 and for glucocorticoid receptor during the estrous cycle. Level of 11beta-hydroxysteroid dehydrogenase type 1 mRNA is higher at the regressed state than at the other stages, whereas level of 11beta-hydroxysteroid dehydrogenase type 2 mRNA is lower at the regressed stage than at the other stages 694281
Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.14920alpha-hydroxysteroid dehydrogenase corpus luteum - 737453, 741393
Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.14920alpha-hydroxysteroid dehydrogenase corpus luteum transcripts of galectin-3 are restricted to corpus luteum and always coincident to the expression of 20alpha-hydroxysteroid dehydrogenase. In the nonpregnant ovary, signals for both galectin-1 and -3 are intense in the old, regressing corpora lutea formed at previous estrous cycles. In the newly formed corpora lutea, the signal intensity of galectin-1 first increases at the starting point of regression followed by increasing galectin-3/20alpha-hydroxysteroid dehydrogenase expressions. Under gestation with active progesterone production, signals for both galectin-1 and -3 in corpora lutea completely disappear. At the perinatal stage, intense expressions of galectin-3/20alpha-hydroxysteroid dehydrogenase recover in the remaining corpora lutea of gestation with the temporal expression of galectin-1 and continue until weaning 688136
Show all pathways known for 1.1.1.188Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.188prostaglandin-F synthase corpus luteum at days 12-14 of pregnancy and the estrous cycle, the expression of prostaglandin E2 synthase, prostaglandin F synthase, and carbonyl reductase/prostaglandin 9-ketoreductase genes and prostaglandin E2 synthase/prostaglandin F synthase ratio are significantly higher in corpora lutea of the pregnant gilts compared to the corpora lutea from the parallel ovaries of the cyclic gilts. There is no difference in expression of prostaglandin E2 synthase, prostaglandin F synthase, and carbonyl reductase/prostaglandin 9-ketoreductase genes and prostaglandin E2 synthase/prostaglandin F synthase ratio between corpora lutea ipsi- and contralateral to the uterine horn with the developing embryos 689092
Show all pathways known for 1.1.1.188Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.188prostaglandin-F synthase corpus luteum high expression level of the lung-type and the microsomal endometrium-type isozymes 661605
Show all pathways known for 1.1.1.188Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.188prostaglandin-F synthase corpus luteum no or very low expression of prostaglandin F2alpha synthase synthase 684436
Show all pathways known for 1.1.1.189Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.189prostaglandin-E2 9-reductase corpus luteum - 657211
Show all pathways known for 1.1.1.189Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.189prostaglandin-E2 9-reductase corpus luteum at days 12-14 of pregnancy and the estrous cycle, the expression of prostaglandin E2 synthase, prostaglandin F synthase, and carbonyl reductase/prostaglandin 9-ketoreductase genes and prostaglandin E2 synthase/prostaglandin F synthase ratio are significantly higher in corpora lutea of the pregnant gilts compared to the corpora lutea from the parallel ovaries of the cyclic gilts. There is no difference in expression of prostaglandin E2 synthase, prostaglandin F synthase, and carbonyl reductase/prostaglandin 9-ketoreductase genes and prostaglandin E2 synthase/prostaglandin F synthase ratio between corpora lutea ipsi- and contralateral to the uterine horn with the developing embryos 689092
Show all pathways known for 1.1.1.189Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.189prostaglandin-E2 9-reductase corpus luteum detection of immunosignals in all luteal cells. Enzymic activity is higher in late corpus luteum. Results support the idea that cyclooxygenase, nitric oxide synthase, and prostaglandin E2 9-ketoreductase regulate buffalo corpus luteum life span 725914
Show all pathways known for 1.1.1.189Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.189prostaglandin-E2 9-reductase corpus luteum expression of CBR1 mRNA and protein is constant during the cycle and pregnancy 701271
Show all pathways known for 1.1.1.189Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.189prostaglandin-E2 9-reductase corpus luteum pseudopregnant rabbits 389468
Display the reaction diagram Show all sequences 1.1.1.2103beta(or 20alpha)-hydroxysteroid dehydrogenase corpus luteum enzyme activity during stages of pseudo-pregnancy, 20alpha-hydroxysteroid dehydrogenase activity increases from day 1 to day 12, overview 657329
Show all pathways known for 1.1.1.239Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.2393alpha(17beta)-hydroxysteroid dehydrogenase (NAD+) corpus luteum - 287209
Show all pathways known for 1.1.1.270Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.2703beta-hydroxysteroid 3-dehydrogenase corpus luteum cell culture 762607
Show all pathways known for 1.1.1.51Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.513(or 17)beta-hydroxysteroid dehydrogenase corpus luteum - 677079
Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.6217beta-estradiol 17-dehydrogenase corpus luteum - 670031, 675190
Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.6217beta-estradiol 17-dehydrogenase corpus luteum detectable throughout the luteal phase of the ovarian cycle and during pregnancy 654934
Display the word mapDisplay the reaction diagram Show all sequences 1.1.1.B4011beta-hydroxysteroid dehydrogenase (NAD+) corpus luteum expression of mRNA for 11beta-hydroxysteroid dehydrogenase type 1, 11beta-hydroxysteroid dehydrogenase type 2 and for glucocorticoid receptor during the estrous cycle. Level of 11beta-hydroxysteroid dehydrogenase type 1 mRNA is higher at the regressed state than at the other stages, whereas level of 11beta-hydroxysteroid dehydrogenase type 2 mRNA is lower at the regressed stage than at the other stages 694281
Display the word mapDisplay the reaction diagram Show all sequences 1.14.11.67[histone H3]-trimethyl-L-lysine4 demethylase corpus luteum - 690008
Display the word mapDisplay the reaction diagram Show all sequences 1.14.11.67[histone H3]-trimethyl-L-lysine4 demethylase corpus luteum histone H3-K4 demethylase is restricted to the corpus luteum 690008
Show all pathways known for 1.14.15.6Display the word mapDisplay the reaction diagram Show all sequences 1.14.15.6cholesterol monooxygenase (side-chain-cleaving) corpus luteum - 285423
Show all pathways known for 1.14.15.6Display the word mapDisplay the reaction diagram Show all sequences 1.14.15.6cholesterol monooxygenase (side-chain-cleaving) corpus luteum primary, from corpora lutea at day 6 to 10 of the estrous cycle, semi-quatitative enzyme expression analysis 676926
Show all pathways known for 1.14.15.6Display the word mapDisplay the reaction diagram Show all sequences 1.14.15.6cholesterol monooxygenase (side-chain-cleaving) corpus luteum specific expressionin luteal cells, no expression in endothelial cells lining the blood vessels 688147
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1prostaglandin-endoperoxide synthase corpus luteum PTGS1 enzyme activity is higher in late corpora lutea and lower in regressive ones 727567
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1prostaglandin-endoperoxide synthase corpus luteum PTGS2 increases from early to late corpora lutea and lowers in regressive ones 727567
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1prostaglandin-endoperoxide synthase corpus luteum significant increase in mRNA for PGHS-2 after treatment with prostaglandin F2alpha. PGHS-1 mRNA content remains unchanged 658374
Show all pathways known for 1.18.1.6Display the word mapDisplay the reaction diagram Show all sequences 1.18.1.6adrenodoxin-NADP+ reductase corpus luteum - 719386
Display the reaction diagram Show all sequences 2.4.3.1beta-galactoside alpha-(2,6)-sialyltransferase corpus luteum - 758875
Display the word mapDisplay the reaction diagram Show all sequences 2.7.1.137phosphatidylinositol 3-kinase corpus luteum - 640875
Display the word mapDisplay the reaction diagram Show all sequences 2.7.11.25mitogen-activated protein kinase kinase kinase corpus luteum highest expression. In pigs, isoform MAP3K8 expression is higher in mature corpus luteums (or those of the mid-luteal phase) than in regressing corpus luteums (late luteal phase) 762367
Show all pathways known for 2.7.7.1Display the word mapDisplay the reaction diagram Show all sequences 2.7.7.1nicotinamide-nucleotide adenylyltransferase corpus luteum activity is high during mid luteal phase, when corpora lutea are mature with respect to structure and function, while it dramatically decreases following PGF2alpha analog injection 661539
Display the word mapDisplay the reaction diagram Show all sequences 3.1.1.13sterol esterase corpus luteum - 133848, 133851, 133853
Show all pathways known for 3.1.2.20Display the word mapDisplay the reaction diagram Show all sequences 3.1.2.20acyl-CoA hydrolase corpus luteum MTE-II is strongly upregulated in corpus luteum during pregnancy 666795
Show all pathways known for 3.1.3.5Display the word mapDisplay the reaction diagram Show all sequences 3.1.3.55'-nucleotidase corpus luteum - 707006
Display the word mapDisplay the reaction diagram Show all sequences 3.1.6.2steryl-sulfatase corpus luteum weak immunostaining of STS irrespective of the oestrus cycle stage 751416
Display the word mapDisplay the reaction diagram Show all sequences 3.1.6.8cerebroside-sulfatase corpus luteum - 692081
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.26prolyl oligopeptidase corpus luteum - 754790
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.55caspase-2 corpus luteum at estrus, activity is 7.6fold greater in the old corpus luteum compared to new corpus luteum 666898
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.55caspase-2 corpus luteum immunostaining for caspase-2 increases as the luteal phase progresses 666898
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.62caspase-9 corpus luteum activity increases transiently at mid-late luteal phase 665826
Display the word mapDisplay the reaction diagram Show all sequences 3.4.22.62caspase-9 corpus luteum caspase-9 activity increases in the old corpus luteum at estrus, during the functional luteolysis 666898
Display the reaction diagram Show all sequences 3.4.24.62magnolysin corpus luteum - 31370, 31375, 31376, 668826
Display the reaction diagram Show all sequences 3.4.24.62magnolysin corpus luteum day 7-8 after heat period 31372
Show all pathways known for 5.3.99.3Display the word mapDisplay the reaction diagram Show all sequences 5.3.99.3prostaglandin-E synthase corpus luteum - 692088
Show all pathways known for 5.3.99.3Display the word mapDisplay the reaction diagram Show all sequences 5.3.99.3prostaglandin-E synthase corpus luteum from women undergoing treatment for infertility, expression of mPGES-2, mPGES-1, and cPGES 668886
Show all pathways known for 5.3.99.3Display the word mapDisplay the reaction diagram Show all sequences 5.3.99.3prostaglandin-E synthase corpus luteum highest abundance of the protein 661605
Show all pathways known for 5.3.99.3Display the word mapDisplay the reaction diagram Show all sequences 5.3.99.3prostaglandin-E synthase corpus luteum mPEGS-2 667830
Show all pathways known for 5.3.99.4Display the word mapDisplay the reaction diagram Show all sequences 5.3.99.4prostaglandin-I synthase corpus luteum widely distributed among different cell types, specific binding sites which may mediate luteotropic actions of the enzyme are only present in small and large luteal cells 37482
Results 1 - 53 of 53
download as CSV
download all results as CSV